Image Rx Lens Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 29-12-2024
- Paid Up Capital ₹ 4.50 M
as on 29-12-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 1.39 Cr
as on 29-12-2024
- Revenue -16.23%
(FY 2020)
- Profit -9274.58%
(FY 2020)
- Ebitda -71.99%
(FY 2020)
- Net Worth -27.70%
(FY 2020)
- Total Assets -4.36%
(FY 2020)
About Image Rx Lens
The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.50 M.
The company has closed loans amounting to ₹1.39 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Deepak Thaliyil, Sunoben, and Bijin Kuruppamparambil serve as directors at the Company.
- CIN/LLPIN
U33201KL2008PTC022559
- Company No.
022559
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2008
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Image Rx Lens?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Thaliyil  | Managing Director | 06-May-2010 | Current |
| Bijin Kuruppamparambil | Managing Director | 06-Jun-2008 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunoben | Additional Director | 21-Sep-2023 | Current |
Financial Performance of Image Rx Lens.
Image Rx Lens Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 16.23% decrease. The company also saw a substantial fall in profitability, with a 9274.58% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Image Rx Lens?
In 2020, Image Rx Lens had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Sep 2012 | ₹8.65 M | Satisfied |
The Federal Bank Limited Creation Date: 13 Oct 2008 | ₹2.00 M | Satisfied |
The Federal Bank Limited Creation Date: 13 Oct 2008 | ₹3.25 M | Satisfied |
How Many Employees Work at Image Rx Lens?
Unlock and access historical data on people associated with Image Rx Lens, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Image Rx Lens, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Image Rx Lens's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
